Scientific Awards

The Bayer Thrombosis Research Award

The Bayer Thrombosis Research Award has been established in 2011 by support of the Bayer scientists Dr. Frank Misselwitz, Dr. Dagmar Kubitza and Dr. Elizabeth Perzborn who won the “Deutscher Zukunftspreis 2009” for the development of the new anticoagulant Xarelto®. They donated their prize money of €250,000 in order to build the foundation for this new award. Bayer matched the donation by an equal company installment.

The Bayer Thrombosis Research Award honors young scientists for outstanding achievements in

Thrombosis research.

The current focus is particularly on basic and clinical research work promoting a diagnosis, prevention and therapy of thromboembolic diseases (including epidemiology and health policy approaches).

The foundation presents the award every two years with a prize money of €30,000.

Suitable candidates are either working in German-speaking countries or they have completed major parts of their scientific training.

Last updated: October 12, 2011